You are here
Clinical Trials: Cord Blood
Condition: Osteoarthritis, Knee
Interventions: Biological: Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs); Procedure: Marrow cellution
Sponsors: Cytopeutics Sdn. Bhd.; Universiti Kebangsaan Malaysia Medical Centre
Recruiting
Interventions: Biological: Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs); Procedure: Marrow cellution
Sponsors: Cytopeutics Sdn. Bhd.; Universiti Kebangsaan Malaysia Medical Centre
Recruiting
Condition: Knee Osteoarthritis
Interventions: Other: normal saline; Other: Cord Blood Mononuclear Cells (UCB-MNCs)
Sponsor: Lili Cao
Recruiting
Interventions: Other: normal saline; Other: Cord Blood Mononuclear Cells (UCB-MNCs)
Sponsor: Lili Cao
Recruiting
Condition: Bone Nonunion
Interventions: Biological: Umbilical cord blood mononuclear cells; Drug: Staphylococcal Enterotoxin C
Sponsors: Qianfoshan Hospital; Shandong Qilu Stem Cells Engineering Co., Ltd.
Recruiting
Interventions: Biological: Umbilical cord blood mononuclear cells; Drug: Staphylococcal Enterotoxin C
Sponsors: Qianfoshan Hospital; Shandong Qilu Stem Cells Engineering Co., Ltd.
Recruiting
Conditions: High Risk Myeloid Malignancies; Cord Blood Transplant
Intervention: Biological: ECT-001-CB (UM171-Expanded Cord Blood Transplant)
Sponsors: ExCellThera inc.; Memorial Sloan Kettering Cancer Center
Not yet recruiting
Intervention: Biological: ECT-001-CB (UM171-Expanded Cord Blood Transplant)
Sponsors: ExCellThera inc.; Memorial Sloan Kettering Cancer Center
Not yet recruiting
Condition: Alzheimer's Disease
Intervention: Biological: human umbilical cord blood derived mesenchymal stem cells
Sponsors: Samsung Medical Center; Medipost Co Ltd.
Not yet recruiting
Intervention: Biological: human umbilical cord blood derived mesenchymal stem cells
Sponsors: Samsung Medical Center; Medipost Co Ltd.
Not yet recruiting
Condition: Congenital Heart Disease, SRV Dependent
Intervention: Biological: Autologous mononuclear cells
Sponsors: Timothy J Nelson, MD, PhD; Mayo Clinic; University of Oklahoma; Children's Hospital of Philadelphia; Children's Hospital Los Angeles; Children's Hospitals and Clinics of Minnesota; Children's Hospital Colorado; Ochsner Health System; Children's of Alabama; Children's Hospital Medical Center, Cincinnati; The Hospital for Sick Children
Not yet recruiting
Intervention: Biological: Autologous mononuclear cells
Sponsors: Timothy J Nelson, MD, PhD; Mayo Clinic; University of Oklahoma; Children's Hospital of Philadelphia; Children's Hospital Los Angeles; Children's Hospitals and Clinics of Minnesota; Children's Hospital Colorado; Ochsner Health System; Children's of Alabama; Children's Hospital Medical Center, Cincinnati; The Hospital for Sick Children
Not yet recruiting
Condition: Alveolar Cleft
Intervention: Procedure: stem cell transplantation
Sponsor: Makerere University
Not yet recruiting
Intervention: Procedure: stem cell transplantation
Sponsor: Makerere University
Not yet recruiting
Condition: Ulcerative Colitis
Interventions: Drug: Prednisone; Drug: Azathioprine; Drug: Adalimumab; Biological: umbilical cord blood mononuclear cells
Sponsor: Shandong Qilu Stem Cells Engineering Co., Ltd.
Recruiting
Interventions: Drug: Prednisone; Drug: Azathioprine; Drug: Adalimumab; Biological: umbilical cord blood mononuclear cells
Sponsor: Shandong Qilu Stem Cells Engineering Co., Ltd.
Recruiting
Condition: Autism Spectrum Disorder
Intervention: Other: umbilical cord blood mononuclear stem cells
Sponsor: St. Petersburg Bekhterev Research Psychoneurological Institute
Active, not recruiting
Intervention: Other: umbilical cord blood mononuclear stem cells
Sponsor: St. Petersburg Bekhterev Research Psychoneurological Institute
Active, not recruiting
Condition: Leukemia, Myelomonocytic, Acute
Intervention: Drug: umbilical cord blood
Sponsor: First Affiliated Hospital Xi'an Jiaotong University
Not yet recruiting
Intervention: Drug: umbilical cord blood
Sponsor: First Affiliated Hospital Xi'an Jiaotong University
Not yet recruiting
